Design and evaluation of fast dissolving oro-dispersible films of metoclopramide hydrochloride using 32 multifactorial designs

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorYassin G.E.
dc.contributor.authorAbass H.A.
dc.contributor.otherDepartment of Pharmaceutics and Industrial Pharmacy
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherAl-Azhar University
dc.contributor.otherEgypt; Department of Pharmaceutics
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober University for Modern Science and Arts (MSA) University
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:41:41Z
dc.date.available2020-01-09T20:41:41Z
dc.date.issued2016
dc.descriptionScopus
dc.description.abstractObjective: The objective of the present work was to develop and optimize fast dissolving orodispersible films containing metoclopramide hydrochloride using 32 multifactorial designs. Methods: The films were prepared by solvent casting method using hydroxypropyl methyl cellulose E5 (HPMC E5) and sodium starch glycolate (SSG) as two independent variables in three levels in concentration 2.5, 3, 3.5% w/wand 1, 1.5, and 2 % respectively. The percent of in vitro drug release (Y1) and the disintegration time (Y2) were chosen and studied as dependent responses. The prepared films were also evaluated for their weight uniformity, thickness, surface pH, drug content, in vitro disintegration time, in vitro drug release, film stability and mechanical properties as folding endurance. Results: All the films were transparent. The films weight (mg) was ranging from 63. 0.78 to 86. 0.82 while the film thickness (mm) and the folding endurance range from 0.22. 0.53, 50.. 0.58 to 0.32. 0.35 and 90. 0.84 respectively. The drug content (mg %) was studied, and it ranges from 98.24. 1.08 to 99.07. 1.02. It was found that the relative standard deviation (% RSD) met the criteria of USP specification for drug content (>6%). In vitro disintegration time was tested; all films satisfied the requirement of disintegration time for fast dissolving dosage form (<1 min), it ranged from 2.24. 1.75 to 3.18. 1.87 sec. The stability studies revealed no significant differences before and after storage for the all formulations. Conclusion: An optimized metoclopramide HCl film was achieved that could be a benefit to a patient suffering from emesis, in which hydroxypropyl methylcellulose (E5) was used as a film forming polymer in its high level (3.5%) in addition to sodium starch glycolate in its high level (2%). 2016 The Authors.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=19700174810&tip=sid&clean=0
dc.identifier.doihttps://doi.org/
dc.identifier.issn9751491
dc.identifier.otherhttps://doi.org/
dc.identifier.urihttps://t.ly/3GJx5
dc.language.isoEnglishen_US
dc.publisherInnovare Academics Sciences Pvt. Ltden_US
dc.relation.ispartofseriesInternational Journal of Pharmacy and Pharmaceutical Sciences
dc.relation.ispartofseries8
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectUniversity for Modern Sciences and Arts
dc.subjectMSA University
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subject32multifactorial designsen_US
dc.subjectFast dissolving orodispersible filmsen_US
dc.subjectMetoclopramide HCLen_US
dc.subjectOptimizationen_US
dc.subjectaspartameen_US
dc.subjectcitric aciden_US
dc.subjectdisintegrating agenten_US
dc.subjectglycerolen_US
dc.subjecthydroxypropylmethylcelluloseen_US
dc.subjectmannitolen_US
dc.subjectmetoclopramideen_US
dc.subjectpolymeren_US
dc.subjectstarch glycolate sodiumen_US
dc.subjectArticleen_US
dc.subjectdiffusionen_US
dc.subjectdissolutionen_US
dc.subjectdrug designen_US
dc.subjectdrug dosage formen_US
dc.subjectdrug releaseen_US
dc.subjectdrug stabilityen_US
dc.subjectenduranceen_US
dc.subjectfactorial analysisen_US
dc.subjecthumidityen_US
dc.subjectoro dispersible filmen_US
dc.subjectpHen_US
dc.subjectprocess optimizationen_US
dc.subjectregression analysisen_US
dc.subjecttablet disintegration timeen_US
dc.subjectthicknessen_US
dc.subjectweight variationen_US
dc.titleDesign and evaluation of fast dissolving oro-dispersible films of metoclopramide hydrochloride using 32 multifactorial designsen_US
dc.typeArticleen_US
dcterms.isReferencedByAl-Hezaimi, K., Al-Askar, M., Selamhe, Z.F.J.H., Alsarra, I.A., Wang, H.L., Evaluation of novel adhesive film containing ketorolac for post-surgery pain control: A safety and efficacy study (2011) Periodontal, 82, pp. 963-968; Vasisht, N., Gever, L.N., Tagarro, I., Finn, A.L., Single-dose pharmacokinetics offentanylbuccal soluble film (2010) Pain Med, 11, pp. 1017-1023; Finn, A.L., Hill, W.C., Tagarro, I., Gever, L.N., Absorption and tolerability of fentanyl buccalsoluble film (FBSF) in patients with cancer in the presence of oral mucositis (2011) J Pain Res, 4, pp. 245-251; Nishimura, M., Matsuura, K., Tsukioka, T., Yamashita, H., Inagaki, N., Sugiyama, T., In vitro and in vivo characteristics of prochlorperazine oral disintegratingfilm (2009) Int J Pharm, 98, pp. 102-368; Kunte, S., Tandale, P., Fast dissolving strips: A novel approach for the delivery of verapamil (2010) J Pharm BioAllied Sci, 2, pp. 325-328; Arya, A., Handra, A., Sharma, V., Pathak, K., Fast dissolving oral films: An innovative drug delivery and dosage form (2010) Int Chem Technol Res, 2, pp. 576-583; Kelly, H.W., Murphy, S., Beta-adrenergic agonists for acute severe asthma (1992) Ann Pharmacother, 26, pp. 81-91; Patel, R.S., Poddar, S.S., Development and characterization of mucoadhesivebuccal patches of salbutamol sulphate (2009) Curr Drug Delivery, 6, pp. 140-144; Olsson, A., Sheng, Y., Kjellen, E., Pero, R.W., In vivo tumor measurement of DNA damage, DNA repair and DNA pools as indicators of radiosensitization by metochlopramide (1995) Carcinogenesis, 16, pp. 1029-1035; Dollery, C., (1999) Therapeutic drugs, pp. M132-M136. , 2nd ed. Churchill livingstone, Toronto; Harrington, R.A., Hamilton, C.W., Brogden, R.N., Metoclopramide an updated review of its pharmacological properties and clinical use (1983) Drugs, 25, pp. 451-494; Cilurzo, F., Cupone, I.E., Minghetti, P., Selmin, F., Montanari, L., Fast dissolving films made of maltodextrins (2008) Eur J Pharm Biopharm, 70, pp. 895-900; Mashru, R.C., Sutariya, V.B., Sankalia, M.G., Parikh, P.P., Development and evaluation of fast-dissolving film of salbutamol sulphate (2005) Drug Dev Ind Pharm, 31, pp. 25-34; Mahesh, A., Shastri, N., Sadanandam, M., Development of taste masked fast disintegrating films of levocetirizine-dihydrochloride for oral use (2010) Curr Drug Delivery, 7, pp. 21-27; Choudhary, D., Patel, V., Patel, H., Formulation and evaluation of quick dissolving film of levecetrizine di hydrochloride (2011) Int J Pharm Technol, 3, pp. 1740-1749; (2007) USP30-NF25, the United States Pharmacopoeia-National Formulary and its supplements; Hoffmann, E.M., Breitenbach, A., Breitkreutz, J., Advances in orodispersible films for drug delivery (2011) Expert Opin Drug Delivery, 8, pp. 299-316; Misra, R., Amin, A., Formulation development of taste-masked rapidly dissolving films of citrizine hydrochloride (2009) Pharm Technol, 33, pp. 48-56; Vasantha, P.V., Puratchikody, A., Mathew, S.T., Balaraman, A.K., Development and characterization of Eudragit based mucoadhesivebuccal patches of salbutamol sulfate (2011) Saudi Pharm J, 19, pp. 207-214; Chaughary, H., Gauri, S., Rathee, P., Kumar, V., Development and optimizationof fast dissolving oro-dispersible films of granisetron HCl using Box-Behnken statistical design (2013) Bull Faculty Pharm Cairo University, 51, pp. 193-201; Hill, S.W., Varker, A.S., Karlage, K., Myrdal, P.B., Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications (2009) J Manag Care Pharm, 15, pp. 253-261; Raju, S., Sandeep Reddy, P., Anirudh Kumar, V., Deepthi, A., Sreeramulu Reddy, K., Madhava Reddy, P.V., Flash release oral films of metoclopramide hydrochloride for pediatric use: Formulation and in vitro evaluation (2011) J Chem Pharm Res, 3, pp. 636-646; Kumar, P., Kumar, S., Kumar, A., Chander, M., Physicochemical characterization of solid dispersion of cefdinir with PVP K-30 and PEG4000 (2010) Int J Pharm Sci Nanotechnol, 3, pp. 948-956; Patel, T., Patel, L.D., Patel, T., Makwana, S., Patel, T., Enhancement of dissolution of fenofibrate by solid dispersion technique (2010) Int Res Pharm Sci, 1, pp. 127-132
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
11682-Article Text-48703-1-10-20160701.pdf
Size:
381.67 KB
Format:
Adobe Portable Document Format
Description: